Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma

Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian-Qian, Ding, Yi, Lei, Yan, Qi, Cui-Ling, He, Xiao-Dong, Lan, Tian, Li, Jiang-Chao, Gong, Ping, Yang, Xuesong, Geng, Jian-Guo, Wang, Li-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979993/
https://www.ncbi.nlm.nih.gov/pubmed/24719558
http://dx.doi.org/10.7150/ijbs.7723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979993/
https://www.ncbi.nlm.nih.gov/pubmed/24719558
http://dx.doi.org/10.7150/ijbs.7723

Ejemplares similares